Driven by the large-scale development of the global livestock and poultry breeding industry, the internationDrivenal market demand for high-quality veterinary drugs and vaccines continues to grow steadily, especially for antibiotics, antiparasitics, poultry vaccines and disinfectants.
At present, major markets including the EU, the Middle East, South Asia and Southeast Asia have raised stricter requirements for the production standards, registration procedures and dossier preparation of veterinary products. A GMP-based production system, complete quality traceability capabilities, and accurate grasp of the regulatory rules of target markets have become key competitiveness for animal health enterprises to expand into international markets. Looking ahead, the industry will continue to develop in a compliant and professional direction, and enterprises with international registration capabilities and stable supply capacity will usher in more market opportunities.